1/17/2020  5:35:19 PM Chg. -3.00 Volume Bid1/17/2020 Ask1/17/2020 Market Capitalization Dividend Y. P/E Ratio
186.80EUR -1.58% 12,853
Turnover: 2.42 mill.
-Bid Size: - -Ask Size: - 971.58 mill.EUR 0.64% 60.26

Business description

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The three business segments are: Radiation Therapy, Isotope Products and Radiopharma. Eckert & Ziegler was founded in 1997 as a holding company.
 

Management board & Supervisory board

CEO
Dr. Andreas Eckert
Management board
Dr. Harald Hasselmann, Dr. Lutz Helmke
Supervisory board
Prof. Dr. Wolfgang Maennig, Albert Rupprecht, Dr. Edgar Löffler, Frank Perschmann, Jutta Ludwig, Prof. Dr. Helmut Grothe
 

Company data

Name: Eckert & Ziegler Strahlen- und Medizintechnik AG
Address: Robert-Rössle-Str. 10,D-13125 Berlin
Phone: +49-30-941084-0
Fax: +49-30-941084-112
E-mail: info@ezag.de
Internet: www.ezag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 51.97%
IPO date: -

Investor relations

Name: Karolin Riehle
IR phone: +49-30-941084-138
IR Fax: -
IR e-mail: karolin.riehle@ezag.de

Company calendar

CW 14 | 3/31/2020 4th Quarter/Annual Report
CW 20 | 5/12/2020 Interim Report 1st Quarter/3 Months
CW 25 | 6/17/2020 General Shareholder Meeting
CW 33 | 8/13/2020 Interim Report 2nd Quarter/6 Months
CW 46 | 11/10/2020 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
51.97%
Eckert Wagniskapital und Frühphasenfinanzierung GmbH
 
30.80%
JP Morgan Asset Management UK
 
5.04%
LOYS Investment S.A.
 
3.31%
JP Morgan Asset Management Europe
 
3.13%
JPMorgan Funds SICAV
 
3.05%
eigene Aktien
 
2.70%